Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2006-08-01
2006-08-01
Prouty, Rebecca E. (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C435S022000, C435S069100, C435S219000, C435S320100, C435S325000, C435S252300, C435S007400, C530S350000, C536S023200
Reexamination Certificate
active
07083940
ABSTRACT:
The present invention provides nucleotide and amino acid sequences that identify and encode a new protein with homology to pregnancy-associated plasma protein-A (PAPP-A). We denote this protein PAPP-A2. The cDNA encoding PAPP-A2 was derived from human placenta. The present invention also provides for antisense molecules to the nucleotide sequences which encode PAPP-A2, expression vectors for the production of purified PAPP-A2, antibodies capable of binding specifically to PAPP-A2, hybridization probes or oligonucleotides for the detection of PAPP-A2-encoding nucleotide sequences, genetically engineered host cells for the expression of PAPP-A2, use of the protein to produce antibodies capable of binding specifically to the protein, methods for screening for pathologies in pregnant and non-pregnant patients that are based on detection of PAPP-A2 antigen in human body fluids or PAPP-A2-encoding nucleic acid molecules, use of the protein to screen for agents that alter the protease activity of PAPP-A2, use of the protein as a therapeutic target for such agents, and use of the protein as a therapeutic agent in relevant pathological states. Methods for screening for altered focal proliferation states in pregnant and/or non-pregnant patients, which include detecting levels of PAPP-A2, are also described. The present invention also provides the identification of a natural substrate of PAPP-A2, insulin-like growth factor binding protein (IGFBP)-5.
REFERENCES:
patent: 6656700 (2003-12-01), Gu et al.
patent: 2002/0102252 (2002-08-01), Gu et al.
patent: WO 01 958 55 (2001-06-01), None
Witkowski et al., Biochemistry 38:11643-11650, 1999.
Broun et al., Science 282:1315-1317, 1998.
Van de Loo et al., Proc. Natl. Acad. Sci. 92:6743-6747, 1995.
Seffernick et al. , J. Bacteriol. 183(8):2405-2410, 2001.
Haaning et al., PIR accession No. S65464, Nov. 1996.
Lawrence J B et al, “The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A”, Proc.Natl. Acad. Sci, USA, vol. 96, pp. 3149-3153, Mar. 1999.
Kristensen T et al., “Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA”, Biochemistry, 33, 1592-1598, Feb. 1994.
Overgaard M T et al, “Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor”, The Journal of Biological Chemistry, vol. 275, No. 40, 6, pp. 31128-31133, Oct. 2000.
Oxvig C et al., “Identification of angiotensionogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma”, The Journal of Biological Chemistry, vol. 270, No. 23, pp. 13645-13651, Issue of Jun. 9, 1995.
Overgaard M T et al, “Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: Expression in human reproductive and nonreproductive tissues”, Biology of Reproduction, 61, 1083-1089, Oct. 1999.
Bonno M et al, “Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta”, Abstract, Laboratory Investigation, vol. 71, No. 4, pp. 560-566, Oct. 1994.
Drmanac R T et al., “Novel nucleic acids and polypeptides”, WO01/75067 Oct. 11, 2001.
Erickson G F et al, “The physiology of folliculogenesis: the role of novel growth factors”, Fertility and Sterility, vol. 76, No. 5, pp. 943-949, Nov. 2001.
Overgaard M T et al., “Insulin-like growth factor binding protein-4 protease”, WO00/54806 Sep. 21, 2000.
Wald N J et al, “First trimester serum screening for Down's Syndrome”, Prenatal Diagnosis, vol. 15, pp. 1227-1240, Dec. 1995.
Christiansen et al., “Qualification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid”, Clinical chemistry, vol. 46, No. 8, Aug. 2000, pp. 1099-1105.
Oxvig C. et al., “Circulating human pregnancy-associated plasma protein-A Is disulfide-bridged to the proform of eosinophil major basic protein”, The Journal of Biological Chemistry, vol. 268, No. 17, Jun. 15, 1993, pp. 12243-12246.
Gordon C S Smith et al., “Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth”, The Journal of Clinical Endocrinology & Metabolism, vol. 87, No. 4, Apr. 2000, pp. 1762-1767.
Guidice L C et al., “Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in the human trophoblasts and endometrial stroma: Evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation”, The Journal of Clinical Endocrinology & Metabolism vol. 87, No. 5, May 2002 pp. 2359-2366.
Martin Farr, et al., Pregnancy-associated plasma protein-E (PAPP-E), Biochimica el Biophysica Acta 1493 (2000):356-362.
Michael T. Overgaard, et al., Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. The Journal of Biological Chemistry, 276(24):21849-21853 (Jun. 15, 2001).
N.M. Page, et al., The characterization of pregnancy associated plasma protein-E and the identification of an alternative splice variant., Placenta 22:681-687 (2001).
Overgaard Michael Toft
Oxvig Claus
Como Biotech ApS
Cooper Iver P.
Prouty Rebecca E.
Ramierz Delia M.
LandOfFree
Pregnancy-associated plasma protein-A2 (PAPP-A2) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pregnancy-associated plasma protein-A2 (PAPP-A2), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pregnancy-associated plasma protein-A2 (PAPP-A2) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3656822